Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis
- PMID: 29294244
- PMCID: PMC6061180
- DOI: 10.1007/s12035-017-0843-5
Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis
Abstract
Patients with a diagnosis of multiple sclerosis (MS) or major depressive disorder (MDD) share a wide array of biological abnormalities which are increasingly considered to play a contributory role in the pathogenesis and pathophysiology of both illnesses. Shared abnormalities include peripheral inflammation, neuroinflammation, chronic oxidative and nitrosative stress, mitochondrial dysfunction, gut dysbiosis, increased intestinal barrier permeability with bacterial translocation into the systemic circulation, neuroendocrine abnormalities and microglial pathology. Patients with MS and MDD also display a wide range of neuroimaging abnormalities and patients with MS who display symptoms of depression present with different neuroimaging profiles compared with MS patients who are depression-free. The precise details of such pathology are markedly different however. The recruitment of activated encephalitogenic Th17 T cells and subsequent bidirectional interaction leading to classically activated microglia is now considered to lie at the core of MS-specific pathology. The presence of activated microglia is common to both illnesses although the pattern of such action throughout the brain appears to be different. Upregulation of miRNAs also appears to be involved in microglial neurotoxicity and indeed T cell pathology in MS but does not appear to play a major role in MDD. It is suggested that the antidepressant lofepramine, and in particular its active metabolite desipramine, may be beneficial not only for depressive symptomatology but also for the neurological symptoms of MS. One clinical trial has been carried out thus far with, in particular, promising MRI findings.
Keywords: Depression; Desipramine; Immune function; Inflammation; Lofepramine; Multiple sclerosis; Oxidative and nitrosative stress.
Similar articles
-
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.Mol Neurobiol. 2016 Oct;53(8):5191-202. doi: 10.1007/s12035-015-9443-4. Epub 2015 Sep 24. Mol Neurobiol. 2016. PMID: 26399644
-
MicroRNAs, Multiple Sclerosis, and Depression.Int J Mol Sci. 2021 Jul 21;22(15):7802. doi: 10.3390/ijms22157802. Int J Mol Sci. 2021. PMID: 34360568 Free PMC article. Review.
-
Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:1-10. doi: 10.1016/j.pnpbp.2019.03.001. Epub 2019 Mar 5. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30849414 Review.
-
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):769-83. doi: 10.1016/j.pnpbp.2010.06.008. Epub 2010 Jun 16. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20561554 Review.
-
Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2022 Mar 2;114:110481. doi: 10.1016/j.pnpbp.2021.110481. Epub 2021 Nov 24. Prog Neuropsychopharmacol Biol Psychiatry. 2022. PMID: 34826557 Review.
Cited by
-
Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment.Pharmaceuticals (Basel). 2024 Jul 25;17(8):983. doi: 10.3390/ph17080983. Pharmaceuticals (Basel). 2024. PMID: 39204088 Free PMC article. Review.
-
A novel probiotic formula, BLLL, ameliorates chronic stress-induced depression-like behaviors in mice by reducing neuroinflammation and increasing neurotrophic factors.Front Pharmacol. 2024 Jul 26;15:1398292. doi: 10.3389/fphar.2024.1398292. eCollection 2024. Front Pharmacol. 2024. PMID: 39130643 Free PMC article.
-
Advances in research on immunocyte iron metabolism, ferroptosis, and their regulatory roles in autoimmune and autoinflammatory diseases.Cell Death Dis. 2024 Jul 4;15(7):481. doi: 10.1038/s41419-024-06807-2. Cell Death Dis. 2024. PMID: 38965216 Free PMC article. Review.
-
Depression and anxiety in multiple sclerosis. Review of a fatal combination.J Neural Transm (Vienna). 2024 Aug;131(8):847-869. doi: 10.1007/s00702-024-02792-0. Epub 2024 Jun 13. J Neural Transm (Vienna). 2024. PMID: 38869643 Review.
-
Clinical and psychological aspects in a group of allergic asthma patients and the impact on their health status perception.Health Psychol Rep. 2023 Sep 5;11(4):321-330. doi: 10.5114/hpr/168790. eCollection 2023. Health Psychol Rep. 2023. PMID: 38178964 Free PMC article.
References
-
- Naegele M, Martin R. The good and the bad of neuroinflammation in multiple sclerosis. Handb Clin Neurol. 2014;122:59–87. - PubMed
-
- Zindler E, Zipp F. Neuronal injury in chronic CNS inflammation. Best Pract Res Clin Anaesthesiol. 2010;24(4):551–562. - PubMed
-
- Feinstein A, Magalhaes S, Richard J-F, Audet B, Moore C. The link between multiple sclerosis and depression. Nat Rev Neurol. 2014;10(9):507–517. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical